Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg. [PDF]
Lin LW +7 more
europepmc +1 more source
Daptomycin failure in the treatment of Enterococcus faecium bacteremia: microbiological insights and the importance of dual therapy including beta-lactam. [PDF]
Luque Paz D, Tattevin P.
europepmc +1 more source
Ceftaroline for Methicillin-Resistant Staphylococcus aureus Endovascular Infection. [PDF]
Cosimi RA +5 more
europepmc +1 more source
Revealing the Fate of Isomeric Monounsaturated Fatty Acids in <i>Enterococcus faecalis</i> Membrane Lipids and Their Influence on Antimicrobial Susceptibility. [PDF]
Casey RL +3 more
europepmc +1 more source
Daptomycin-Induced Eosinophilic Pneumonia in a Patient With Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Undergoing Hemodialysis: A Case Report. [PDF]
Alsawadi BH, Beitar FS, Ghunaim RS.
europepmc +1 more source
Managing <i>Enterococcus faecium</i> bloodstream infection: a Delphi document on clinical recommendations and research agenda. [PDF]
Rinaldi M +28 more
europepmc +1 more source
Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in <i>Staphylococcus capitis</i> NRCS-A from neonatal sepsis and NEC. [PDF]
Kränkel L +12 more
europepmc +1 more source
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction? [PDF]
Cojutti PG +5 more
europepmc +1 more source
Differential Impact of Ergosterol on Yeast Membranes Exposed to Membrane-Targeting Antimicrobial Compounds. [PDF]
Villacres JI, Shaikhet M, Avis TJ.
europepmc +1 more source
Understanding Daptomycin Resistance Mechanisms and Treatment Challenges in <i>Enterococcus faecium</i> Infection: A Case Series. [PDF]
Nair-Collins S +8 more
europepmc +1 more source

